- About Us
- Nano-Social Network
- Nano Consulting
- My Account
December 11th, 2007
Piper Jaffray initiates coverage on Nanosphere (Nasdaq: NSPH) with a Buy rating and a $17 price target.
The firm said Nanosphere's core technology is solid and its recent FDA approval for its Verigene molecular diagnostics instrument will lead to long-term revenue growth.
|Related News Press|
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Harris & Harris Group Announces a Proposed Strategic Restructuring December 20th, 2016
In-cell molecular sieve from protein crystal February 14th, 2017
Cedars-Sinai, UCLA Scientists Use New ‘Blood Biopsies’ With Experimental Device to Speed Cancer Diagnosis and Predict Disease Spread: Leading-Edge Research Is Part of National Cancer Moonshot Initiative February 13th, 2017
Breakthrough with a chain of gold atoms: In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport February 20th, 2017